HARBIN MEDISAN PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.28 CNY | -2.28% |
|
+3.63% | -24.69% |
| Apr. 26 | Harbin Medisan Pharmaceutical Co., Ltd. Proposes Final Dividend for 2023 | CI |
| Apr. 26 | Medisan Pharma's Potassium Chloride Injection Passes Drug Regulator's Evaluation | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 1.03B 142M | Sales 2023 | 1.19B 164M | Capitalization | 4.23B 585M |
|---|---|---|---|---|---|
| Net income 2022 | 30M 4.15M | Net income 2023 | 73M 10.1M | EV / Sales 2022 | 3.49 x |
| Net cash position 2022 | 637M 88.2M | Net cash position 2023 | 331M 45.75M | EV / Sales 2023 | 3.28 x |
| P/E ratio 2022 |
137
x | P/E ratio 2023 |
56.9
x | Employees | 1,721 |
| Yield 2022 |
0.73% | Yield 2023 |
-
| Free-Float | 32.95% |
More Fundamentals
* Assessed data
More news
| 1 day | -2.28% | ||
| 1 week | +3.63% | ||
| Current month | +3.63% | ||
| 1 month | +0.10% | ||
| 3 months | +26.76% | ||
| 6 months | -24.74% | ||
| Current year | -24.69% |
1 week
9.98
10.69
1 month
9.2814.40
Current year
6.7414.40
1 year
6.7415.49
3 years
6.7436.99
5 years
6.7436.99
10 years
6.7436.99
| Managers | Title | Age | Since |
|---|---|---|---|
Jian Fei Qin
CEO | Chief Executive Officer | 61 | 13-12-23 |
Zhi Cheng Zhao
DFI | Director of Finance/CFO | 49 | 21-03-04 |
Dan Fei Liang
BRD | Director/Board Member | 57 | 13-12-23 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Fu Sheng Wang
BRD | Director/Board Member | 60 | 19-12-17 |
Hongquan Liu
BRD | Director/Board Member | 65 | 22-03-16 |
Jian Fei Qin
CEO | Chief Executive Officer | 61 | 13-12-23 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-10 | 10.28 | -2.28% | 7,333,300 |
| 24-05-09 | 10.52 | +1.35% | 9,153,557 |
| 24-05-08 | 10.38 | -1.70% | 9,020,850 |
| 24-05-07 | 10.56 | +1.34% | 13,147,550 |
End-of-day quote Shenzhen S.E., May 09, 2024
More quotes
HARBIN MEDISAN PHARMACEUTICAL CO LTD is a China-based company principally engaged in the research and development, production and sales of chemical preparations, active pharmaceutical ingredients (APIs), medical devices and cosmetics. Its medicines cover the nervous system, cardio-cerebrovascular, systemic anti-infection, musculoskeletal, nutritional infusion, and body fluid balance infusion therapeutic fields. The Company's products include freeze-dried powder injections, small volume injections, large infusion products, solid preparations, medical devices and cosmetics. The Company mainly distributes its products within domestic market.
Sector
Pharmaceuticals
Calendar
2024-05-16
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| -24.69% | 440M | |
| +30.38% | 684B | |
| +26.51% | 568B | |
| -4.36% | 361B | |
| +19.30% | 329B | |
| +3.73% | 284B | |
| +16.70% | 240B | |
| +8.78% | 208B | |
| -7.93% | 200B | |
| +7.68% | 166B |
- Stock Market
- Equities
- 002900 Stock
